AI assistant
Sending…
Corvus Pharmaceuticals, Inc. — Director's Dealing 2017
Jan 4, 2017
32755_dirs_2017-01-04_57ca276e-0cae-40ef-bd15-90f14677311e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2017-01-03
Reporting Person: CLARK IAN T (Director)
More from Corvus Pharmaceuticals, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 7
Major Shareholding Notification
2026
Mar 26
Major Shareholding Notification
2026
Feb 5
Major Shareholding Notification
2026
Jan 30
Director's Dealing
2026
Jan 30
Major Shareholding Notification
2026
Jan 27
Regulatory Filings
2026
Jan 23
Regulatory Filings
2026
Jan 23
Regulatory Filings
2026
Jan 20